Fresenius Kabi

Founded: 1999 • Age: 27 yrs
Healthcare solutions in pharmaceuticals, nutrition, MedTech, and biopharmaceuticals.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Fresenius Kabi

Fresenius Kabi is a company founded in 1999. Fresenius Kabi has completed 4 acquisitions, including Akorn, Fenwalinc and Ivenix. Fresenius Kabi offers products and services including IV Drugs and Infusion Therapy and Medical Nutrition.

  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Social
    *********
  • Legal Name Fresenius Kabi Ag
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Akorn

    & 3 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Fresenius Kabi

Fresenius Kabi offers a comprehensive portfolio of products and services, including IV Drugs and Infusion Therapy and Medical Nutrition.

Primary

IV therapy products are supplied by Fresenius Kabi for anesthetics, oncology, anti-infectives, and critical care to enhance patient outcomes.

Specialized nutrition solutions are offered by Fresenius Kabi, including parenteral and enteral nutrition for various patient needs.

People of Fresenius Kabi

Headcount 10000+
Employee Profiles 367
Employee Profiles
People
Lynn McCready
Country Manager
People
Conor Sadlier
National Sales Manager Pharma Ireland
People
Steve Phillips
Senior Director, Immunology Biosimilar Sales
People
Thorben Adami
Director Strategic Data Analytics | Corporate Development

Unlock access to complete

Funding Insights of Fresenius Kabi

Investments & Acquisitions by Fresenius Kabi

Fresenius Kabi has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Akorn, Fenwalinc and Ivenix.

Investments
Acquisitions
Company Name Description Domain Location Founded Year Amount
Antibodies, cytokines, and hormones are developed, manufactured, and commercialized.
2009
Infusion management systems are developed with wireless web-based architecture.
2001
Portfolio of products for transfusion medicine and cell therapy.
1949

Financial Statements - Fresenius Kabi

Fresenius Kabi Comparisons

+
Add Comparison
Available on Premium

Competitors of Fresenius Kabi

Frequently Asked Questions about Fresenius Kabi

Fresenius Kabi was founded in 1999.

Fresenius Kabi is recognized as a global provider of healthcare products and services, with a focus on lifesaving medicines and technologies for critically ill patients. Its portfolio includes IV drugs, medical nutrition, and biopharmaceuticals that are utilized to support patient care worldwide. Sustainability efforts are emphasized, including reductions in emissions and community support, while maintaining high-quality standards. The companys global presence and commitment to ethical practices are noted in its operations from Bad Homburg, Germany, touching the lives of millions annually through innovative healthcare solutions.

Fresenius Kabi offers IV Drugs and Infusion Therapy and Medical Nutrition.

Fresenius Kabi has made 4 acquisitions, including Akorn, Fenwalinc, and Ivenix.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available